Publication | Open Access

A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study

ObesityMetabolic SyndromeDiabetes ManagementInsulin ManagementDiabetesType 2Non-inferiority StudyDiabetes MellitusTwice-daily ExenatideInsulin DeliveryMedicine